Teva Urges Judge To Limit Walgreens, CVS Antitrust Claims
By Hannah Albarazi (January 5, 2022, 7:02 PM EST) -- Teva Pharmaceuticals urged a California federal judge Wednesday to curb antitrust claims brought by Walgreens, CVS and other retailers alleging that the pharmaceutical giant conspired with rival Gilead to keep generic versions of blockbuster HIV treatments off the market, arguing that some of the retailers' claims are time-barred.
Teva Pharmaceuticals USA's counsel told U.S. District Judge Edward M. Chen during a remote hearing that the retailers cannot seek relief for alleged overcharges on purchases that were made more than four years before the filing of their own complaint.
Alleged injuries that occurred before September 2017 are outside the four-year statute of...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!